` GMED (Globus Medical Inc) vs S&P 500 Comparison - Alpha Spread

GMED
vs
S&P 500

Over the past 12 months, GMED has significantly outperformed S&P 500, delivering a return of 43% compared to the S&P 500's 6% growth.

Stocks Performance
GMED vs S&P 500

Loading

Performance Gap
GMED vs S&P 500

Loading
GMED
S&P 500
Difference

Performance By Year
GMED vs S&P 500

Loading
GMED
S&P 500
Add Stock

Competitors Performance
Globus Medical Inc vs Peers

Globus Medical Inc
Glance View

Economic Moat
None
Market Cap
9.9B USD
Industry
Health Care

Globus Medical Inc., founded in 2003, has crafted a distinctive narrative in the landscape of medical technology, rooted in innovation and practicality. Emerging from a profound understanding of spinal pathologies, the company has steadily risen to become a pivotal player in the musculoskeletal sector. Its journey is steered by a commitment to addressing complex spine disorders through the development of cutting-edge products that are not only innovative but also substantially user-friendly for both surgeons and patients. This fusion of technology and practicality is what sets Globus Medical apart. The company relentlessly focuses on expanding its product offerings through significant investments in research and development, continuously pushing the envelope in areas such as minimally invasive surgery, advanced surgical approaches, and imaging, which form the core of its business operations. The heart of Globus Medical's revenue model lies in its expansive product portfolio that serves surgeons and healthcare institutions globally. Their financial engine is powered by the sales of implants and related surgical instruments, meticulously designed to improve surgical outcomes. These products span a wide array of offerings including but not limited to advanced minimally invasive techniques and sophisticated trauma solutions. Beyond the traditional revenue streams, Globus Medical has ventured into promising areas like robotic surgery, thereby augmenting its revenue sources while accessing the benefits of technological advancements. This strategic direction not only strengthens its market position but also ensures it stays at the forefront of providing value-based solutions in the ever-evolving healthcare landscape. By integrating its technological prowess with a deep understanding of clinical needs, Globus Medical continues to carve a robust path for sustainable growth and leadership in the medtech sector.

GMED Intrinsic Value
86.19 USD
Undervaluation 17%
Intrinsic Value
Price
Back to Top